Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor

The retinoblastoma tumor suppressor protein (pRB) is a major regulator of cell-cycle progression and cellular differentiation. Central to pRB function is the pocket domain, which serves as the main binding region for cellular regulators. In tumors pRB is frequently inactivated by mutations in the pocket domain or by binding of viral oncoproteins to this region. A characteristic feature of these viral oncoproteins and many cellular pRB-binding partners is an LxCxE sequence motif, which interacts with pRB's pocket domain. Here, we show that the ubiquitin-like modifier SUMO is covalently attached to a distinct residue (K720) of pRB within the B-box of the pocket region that binds LxCxE-motif proteins. We provide evidence that SUMO preferentially targets the active, hypophosphorylated form of pRB and show that tumorigenic mutations of pRB in the pocket domain lead to a loss of SUMOylation. Notably, the level of pRB SUMOylation is controlled by the interaction of pRB with viral and cellular LxCxE-motif proteins. Inhibitors of pRB function, including the viral oncoproteins E1A and E7 and the cellular E1A-like inhibitor of differentiation EID-1, completely abolish SUMO modification of pRB. Conversely, pRB mutants deficient in binding of LxCxE-motif proteins exhibit a drastically enhanced modification by SUMO. Finally, we provide evidence that SUMOylation can influence pRB function, as the SUMO-deficient pRBK720R mutant exerts a slightly higher repressive potential on an E2F-responsive reporter gene than wild-type pRB. Taken together, these data identify SUMO modification as a novel post-translational modification of pRB that may control pRB activity by modulating LxCxE–pocket interactions.

[1]  Jie-Oh Lee,et al.  Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7 , 1998, Nature.

[2]  S. Müller,et al.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  L. Magnaghi-Jaulin,et al.  Retinoblastoma protein represses transcription by recruiting a histone deacetylase , 1998, Nature.

[4]  Tony Kouzarides,et al.  Retinoblastoma protein recruits histone deacetylase to repress transcription , 1998, Nature.

[5]  J. Harbour,et al.  The Rb/E2F pathway: expanding roles and emerging paradigms. , 2000, Genes & development.

[6]  B. Gallie,et al.  The B-Domain Lysine Patch of pRB Is Required for Binding to Large T Antigen and Release of E2F by Phosphorylation , 2002, Molecular and Cellular Biology.

[7]  Merlin Crossley,et al.  Modification with SUMO , 2003, EMBO reports.

[8]  F. Melchior,et al.  SUMO--nonclassical ubiquitin. , 2000, Annual review of cell and developmental biology.

[9]  M. Krstic-Demonacos,et al.  Acetylation control of the retinoblastoma tumour-suppressor protein , 2001, Nature Cell Biology.

[10]  W. Sellers,et al.  Cells Degrade a Novel Inhibitor of Differentiation with E1A-Like Properties upon Exiting the Cell Cycle , 2000, Molecular and Cellular Biology.

[11]  D. Riley,et al.  Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Dick,et al.  Three Regions of the pRB Pocket Domain Affect Its Inactivation by Human Papillomavirus E7 Proteins , 2002, Journal of Virology.

[13]  S. Ao,et al.  Identification and characterization of a novel human cDNA encoding a 21 kDa pRb-associated protein. , 2001, Gene.

[14]  Sibylle Mittnacht,et al.  Differential Phosphorylation of the Retinoblastoma Protein by G1/S Cyclin-dependent Kinases* , 1997, The Journal of Biological Chemistry.

[15]  R. DePinho,et al.  SUMO-1 Modification of Histone Deacetylase 1 (HDAC1) Modulates Its Biological Activities* , 2002, The Journal of Biological Chemistry.

[16]  F. McCormick,et al.  The RB and p53 pathways in cancer. , 2002, Cancer cell.

[17]  J. Harbour,et al.  Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1 , 1999, Cell.

[18]  A. Sharrocks,et al.  SUMO promotes HDAC-mediated transcriptional repression. , 2004, Molecular cell.

[19]  Linda Smith,et al.  Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein , 2001, Oncogene.

[20]  H. Hirai,et al.  Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro. , 2004, Biochemical and biophysical research communications.

[21]  M. Kagey,et al.  The Polycomb Protein Pc2 Is a SUMO E3 , 2003, Cell.

[22]  N. Perkins,et al.  P300 transcriptional repression is mediated by SUMO modification. , 2003, Molecular cell.

[23]  Erica S. Johnson,et al.  An E3-like Factor that Promotes SUMO Conjugation to the Yeast Septins , 2001, Cell.

[24]  Erica S. Johnson,et al.  Protein modification by SUMO. , 2004, Annual review of biochemistry.

[25]  A. Dejean,et al.  Nuclear and unclear functions of SUMO , 2003, Nature Reviews Molecular Cell Biology.

[26]  S. Reed,et al.  Cyclin E-induced S phase without activation of the pRb/E2F pathway. , 1997, Genes & development.

[27]  N. Dyson,et al.  Retinoblastoma protein partners. , 2001, Advances in cancer research.

[28]  S. Müller,et al.  SUMO: a regulator of gene expression and genome integrity , 2004, Oncogene.

[29]  Michael D. Schneider,et al.  A Novel Rb- and p300-Binding Protein Inhibits Transactivation by MyoD , 2000, Molecular and Cellular Biology.

[30]  C. Sherr,et al.  Principles of Tumor Suppression , 2004, Cell.

[31]  D. Dean,et al.  Role of the LXCXE Binding Site in Rb Function , 2000, Molecular and Cellular Biology.

[32]  A. Lassar,et al.  pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation , 1999, Current Biology.

[33]  S. Müller,et al.  PIAS/SUMO: new partners in transcriptional regulation , 2003, Cellular and Molecular Life Sciences CMLS.

[34]  A. Dejean,et al.  The Nucleoporin RanBP2 Has SUMO1 E3 Ligase Activity , 2002, Cell.

[35]  E. Harlow,et al.  The retinoblastoma tumour suppressor in development and cancer , 2002, Nature Reviews Cancer.

[36]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[37]  A. Dejean,et al.  c-Jun and p53 Activity Is Modulated by SUMO-1 Modification* , 2000, The Journal of Biological Chemistry.

[38]  W. C. Forrester,et al.  The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. , 2001, Molecular cell.

[39]  S. Jentsch,et al.  Ubiquitin and proteasomes: Sumo, ubiquitin's mysterious cousin , 2001, Nature Reviews Molecular Cell Biology.

[40]  B. Spike,et al.  New roles for the RB tumor suppressor protein. , 2004, Current opinion in genetics & development.

[41]  Andrew J. Bannister,et al.  Rb targets histone H3 methylation and HP1 to promoters , 2001, Nature.

[42]  D. Nguyen,et al.  Acetylation regulates the differentiation‐specific functions of the retinoblastoma protein , 2004, The EMBO journal.

[43]  E. Miska,et al.  The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase , 2002, The EMBO journal.

[44]  Y. Chen,et al.  Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. , 1996, Genes & development.

[45]  D. Dean,et al.  Rb Interacts with Histone Deacetylase to Repress Transcription , 1998, Cell.

[46]  Yunje Cho,et al.  Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen , 2001, The EMBO journal.

[47]  Jean Y. J. Wang,et al.  Differential Regulation of Retinoblastoma Protein Function by Specific Cdk Phosphorylation Sites (*) , 1996, The Journal of Biological Chemistry.

[48]  F. Dick,et al.  Mutagenesis of the pRB Pocket Reveals that Cell Cycle Arrest Functions Are Separable from Binding to Viral Oncoproteins , 2000, Molecular and Cellular Biology.

[49]  Jeong Ho Chang,et al.  Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. , 2002, Genes & development.

[50]  M. Burghammer,et al.  Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation , 2003, Proceedings of the National Academy of Sciences of the United States of America.